Skip to content
zameds

Fosaprepitant dimeglumine equivaleng to fosaprepitant (Fosaprepitant Cipla)

Fosaprepitant dimeglumine equivaleng to fosaprepitant

Cipla Medpro (Pty) Ltd

Registration

Applicant
Cipla Medpro (Pty) Ltd
Certificate holder
Cipla Medpro (Pty) Ltd
Registrations
1

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Fosaprepitant cipla

EACH VIAL CONTAINS FOSAPREPITANT DIMEGLUMINE EQUIVALENG TO FOSAPREPITANT 150,0 mg

150 mgLyophilised powder for solution for infusion55045255/5.7.2/0452Approved 7 February 2023RegisteredNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles